您的位置:首页 > 产品展厅 > 化工原料 > 化学试剂 > 生化试剂 > GSK-0660 货号2897-25
【GSK-0660 货号2897-25】齐一生物专业代理Sigma西格玛.美国BD.赛默飞.日本wako.TCL.默克Merck .美国AMRESCO.日本荣研化学株式会社.EP(欧洲药典).USP(美国药典).BP(英国药典)加拿大TRC等试剂.标准品.对照品齐一生物销售:021-6034 8496;181214 53965;173021 04490网站:www.qiyibio.com【GSK-0660 货号2897-25】
9237380 Installation, BR MDx & 2 react. setup Installation and training, including two customized reaction setup protocols CNY
9237379 Installation, BR MDx & 1 react. setup Installation and training, including one customized reaction setup protocol CNY
9237378 BR MDx, Installation The Installation, BR MDx facilitates the quick implementation of the BioRobot MDx into the lab routine by minimizing the instrument start-up phase. It covers the hardware and software installation of the BioRobot MDx instrument and provides the user with an introductory training on operation and user maintenance. The installation includes labor and travel costs. The performance of the installation process is documented on a GMP/GLP-compliant Field Service document. CNY
9237175 Guard Fan, Platic XYP CNY
9233209 Tubing, 3/2, CNY
9233155 Power Cord, European CNY
9236418 Board, CPU, TWI CNY
9236345 Red LSR CNY
9236166 Safety shield, RapidPlate CNY 【GSK-0660 货号2897-25】
9230863 Anpressplatte Rose-80 CNY
9235538 Teaching Tool CNY
9230282 Cable, RS323, robot to syringe pump, 225 CNY
5050-2002 hc2 Software V2 Package CNY
BS96RNA BioSprint 96 to RNA (384) - UDP CNY
9240730 Tubing, 1/4" OD, Red, AP CNY
9240713 Poly Muffler Kit, AP96/196 CNY
9240690 Bearings, Lead Screws, AP CNY
9243654 Comprehen Valid., Other Quant. Sys. """The Comprehensive Validation Support plan specific to a laboratory's needs will incorporate all of the requirements for the internal validation guidelines from the FBI's Quality Assurance Standards (QAS).
The Comprehensive Validation Support service includes all travel and labor charges for up to 20 days by the QIAGEN Validation Team. Typically, one week will be required to extract, quantify, and amplify the validation study samples and may require multiple individuals. Usually, two weeks is required to analyze the data and one week to write the final report. The expected time period to complete the Comprehensive Validation is six weeks. The actual time may vary depending on resource availability, including laboratory time dedicated to validation activities.
Lab Work – The QIAGEN specialist(s) will travel to the laboratory to conduct the on-site validation lab work. The QIAGEN specialist team will perform and complete all extractions, quantifications, amplfications, and capillary electrophoresis. The laboratory is responsible for providing systems/protocols that may be needed (generally laboratory SOPs, ex. interpretation guidelines). Additionally, the laboratory staff may be required to provide additional data needed for interpretation (ex. quantification/amplification/CE results) during the data review phase of the validation.
Once the final scope of the validation is determined, QIAGEN will provide a quote for all consumables required for the validation. Non-QIAGEN chemistry and accessories are not included and should be purchased to cover the validation experimental design including qPCR, STR, NIST standards, required samples types (blood, semen, buccal samples) and required substrates (swabs, materials, etc). For planning purposes and to ensure a smooth process, the Customer is expected to have all materials on-hand and inventoried one (1) week prior to the validation start date.
Data Analysis – The Comprehensive Validation Support plan encompasses data collection (quants, amps, CE) during the on-site visit. The laboratory may be responsible for sharing (typically electronically via e-mail) any validation data requested after the on-site visit. A QIAGEN specialist will complete all of the data analysis produced from the validation study design. This includes qPCR (quant) and STR (amp) analysis and linkage to starting samples.
Validation data CD/flashdrive – QIAGEN will review the validation data and draft a validation summary document, ensuring compliance with the FBI's QAS requirements/standards. QIAGEN will send validation data in an electronic format (email/CD/flashdrive) to the laboratory. The laboratory is responsible for final compilation, any format change preferences, review and signoff of the validation report. The documentation provided by QIAGEN will aide in demonstrating compliance with all accreditation guidelines during laboratory audits. Should a hard copy of the validation study be preferred, the laboratory is required to specify prior to the onset of the validation.
Post-validation QIAGEN-to-Laboratory Transfer – Following completion of the validation and generation of the draft validation summary document, a designated member of the QIAGEN validation team will review the validation with the Lab Manager and the Technical Leader. Following sign off on the validation report, training of the laboratory DNA staff will occur. Refer to the Post-validation Competency Training for additional information. """ CNY
6000-5013 LumiCheck Plate User Package CNY
288103 bactotype Mycoplasma Mg/Ms PCR Kit (24) CNY
1048147 QIAamp Viral RNA Mini Accessory Set CNY
270043 cattletype BHV1 gB Ab (5) CNY
1019992 Buffer Set (RNeasy 96 BioRobot 9604 Kit CNY
273401 pigtype Toxoplasma Ab (1) CNY
273505 pigtype Trichinella Ab (20) CNY 【GSK-0660 货号2897-25】
9019538 ZLVBelting, flat cogged, 6T, 2.5mm, CASx CNY
9020591 Tray Assembly, DML 3000 CNY
9021007 Motor, Pipettor X, DCU CNY
9013373 Fix kit, liquid handling, BR8000 CNY
9013315 Motor, handler T/L, BR3000 CNY
└ 小梁网细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 视网膜muller细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 角膜内皮细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 脉络膜微血管细胞总RNA 1μg/1μl(10μg/20ug/50ug)
病人肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 食道肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 胃肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug) 【GSK-0660 货号2897-25】
└ 肝肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 结肠肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 直肠肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 肺肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 胆道肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 肾肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 膀胱肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 胰腺肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 甲状腺肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 前列腺肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 乳腺肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 卵巢肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 子宫肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 宫颈肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 皮肤肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 胶质肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug) 【GSK-0660 货号2897-25】
└ 髓母细胞肿瘤组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 胃癌组织原性原代成纤维细胞总RNA 1μg/1μl(10μg/20ug/50ug)
大鼠,小鼠,兔组织源性原代细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 肺微血管内皮细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 肺血管平滑肌细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ Ⅱ型肺泡上皮细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 气管上皮细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 气道平滑肌细胞总RNA 1μg/1μl(10μg/20ug/50ug)
└ 肺成纤维细胞总RNA 1μg/1μl(10μg/20ug/50ug)
① 凡本网注明"来源:易推广"的所有作品,版权均属于易推广,未经本网授权不得转载、摘编或利用其它方式使用。已获本网授权的作品,应在授权范围内
使用,并注明"来源:易推广"。违者本网将追究相关法律责任。② 本网凡注明"来源:xxx(非本网)"的作品,均转载自其它媒体,转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责,且不承担此 类作品侵权行为的直接责任及连带责任。如其他媒体、网站或个人从本网下载使用 ,必须保留本网注明的"稿件来源",并自负版权等法律责任。
③ 如涉及作品内容、版权等问题,请在作品发表之日起两周内与本网联系,否则视为放弃相关权利。
④易推广页面显示产品信息均由企业自主发布,信息内容真实性、准确性与合法性由相关企业负责,易推广对此不承担任何责任,如遇非法或侵权信息欢迎监督,请联系QQ:1273397930或者发邮件至:1273397930@qq.com,如有确实证件证明属实,本站将对其删除处理,谢谢!
⑤ 本信息由注册会员:齐一生物科技(上海)有限公司发布并且负责版权等法律责任。
易推广客服微信